yield10.png
Yield10 Bioscience Outlines Plans for Spring 2017 Field Tests of Novel Yield Trait Gene C3003 in Camelina and Canola
March 13, 2017 09:00 ET | Yield10 Bioscience, Inc.
WOBURN, Mass., March 13, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) today outlined plans for its Spring 2017 field tests of the novel yield trait gene C3003 in Camelina and...
yield10.png
Yield10 Bioscience Reports Promising Greenhouse Results for Second Generation C3003 Trait in Camelina
March 09, 2017 09:00 ET | Yield10 Bioscience, Inc.
WOBURN, Mass., March 09, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) today announced greenhouse results in its model Camelina system showing that its second generation novel...
yield10.png
Yield10 Bioscience to Present at 29th Annual ROTH Conference
March 06, 2017 09:00 ET | Yield10 Bioscience, Inc.
WOBURN, Mass., March 06, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) announced today that Oliver Peoples, Ph.D., President and Chief Executive Officer, will present at the 29th...
yield10.png
Yield10 Bioscience Appoints Richard W. Hamilton, Ph.D. to the Board of Directors
March 02, 2017 09:00 ET | Yield10 Bioscience, Inc.
WOBURN, Mass., March 02, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) today announced that it has appointed Richard W. Hamilton, Ph.D. to its Board of Directors, effective...
yield10.png
Yield10 Bioscience Expands Scientific Team with Two Key Hires
February 16, 2017 10:00 ET | Yield10 Bioscience, Inc.
WOBURN, Mass., Feb. 16, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) today announced that it has expanded its plant science team with two key hires. Karen Bohmert-Tatarev, Ph.D....
yield10.png
University of Missouri Grants Yield10 Bioscience an Exclusive Option to Evaluate Advanced Technology for Oilseed Crops
January 31, 2017 09:00 ET | Yield10 Bioscience, Inc.
WOBURN, Mass., Jan. 31, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN), today announced that the University of Missouri (“MU”) has granted the Company an exclusive one-year option...
yield10.png
Yield10 Bioscience Reports Preliminary 2016 Camelina Field Test Results Showing that the C3003 Trait Produces Significant Improvements in Seed Yield
January 26, 2017 16:05 ET | Yield10 Bioscience, Inc.
WOBURN, Mass., Jan. 26, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) today announced preliminary field test results in its model Camelina system showing that the novel yield trait...
yield10.png
Yield10 Bioscience to Host Investor Conference Call
January 24, 2017 16:05 ET | Yield10 Bioscience, Inc.
WOBURN, Mass., Jan. 24, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) announced today that the Company will host a conference call and live webcast on Thursday, January 26th...
yield10.png
Metabolix Announces Third Quarter 2016 Financial Results
November 09, 2016 16:05 ET | Metabolix
CAMBRIDGE, Mass., Nov. 09, 2016 (GLOBE NEWSWIRE) -- Metabolix, Inc. (NASDAQ:MBLX), today reported financial results for the three months ended September 30, 2016. “We are excited to be moving...
yield10.png
Dr. Kristi Snell Representing Yield10 at Policy Event Focused on Building a 21st Century Agricultural Workforce
October 06, 2016 11:32 ET | Metabolix
WOBURN, Mass., Oct. 06, 2016 (GLOBE NEWSWIRE) -- Metabolix, Inc. (NASDAQ:MBLX), today announced that Kristi Snell, Ph.D. is representing Yield10 Bioscience today at a policy event focused on...